These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6760695)

  • 1. A cell surface marker expressed on cytotoxic peritoneal macrophages and normal lung macrophages.
    Tokunaga T; Akagawa KS; Momoi T
    Adv Exp Med Biol; 1982; 155():429-34. PubMed ID: 6760695
    [No Abstract]   [Full Text] [Related]  

  • 2. Defective tumoricidal capacity of macrophages from P/J mice: tumoricidal defect involves abnormalities in lymphokine-derived activation stimuli and in mononuclear phagocyte responsiveness.
    Boraschi D; Meltzer MS
    J Immunol; 1980 Aug; 125(2):777-82. PubMed ID: 6993563
    [No Abstract]   [Full Text] [Related]  

  • 3. Defective tumoricidal capacity of macrophages from P/J mice: characterization of the macrophage cytotoxic defect after in vivo and in vitro activation stimuli.
    Boraschi D; Meltzer MS
    J Immunol; 1980 Aug; 125(2):771-6. PubMed ID: 6993562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective tumoricidal capacity of macrophages from A/J mice. I. Characterization of the macrophage cytotoxic defect after in vivo and in vitro activation stimuli.
    Boraschi D; Meltzer MS
    J Immunol; 1979 Apr; 122(4):1587-91. PubMed ID: 376720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The induction of cytotoxic macrophages and natural killer cells in congenitally athymic rnu/rnu rats.
    Gray JD; Brooks CG
    Cell Immunol; 1980 Aug; 53(2):405-12. PubMed ID: 6996842
    [No Abstract]   [Full Text] [Related]  

  • 6. Macrophage activation for tumor cytotoxicity: mechanisms of macrophage activation by lymphokines.
    Meltzer MS; Ruco LP; Leonard EJ
    Adv Exp Med Biol; 1979; 121B():381-98. PubMed ID: 397754
    [No Abstract]   [Full Text] [Related]  

  • 7. Specific surface antigens expressed on activated mouse peritoneal macrophages and recognized by a novel monoclonal antibody.
    Someya A
    Immunology; 1985 Dec; 56(4):683-8. PubMed ID: 3908293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective tumoricidal capacity of macrophages from A/J mice. II. Comparison of the macrophage cytotoxic defect of A/J mice with that of lipid A-unresponsive C3H/HeJ mice.
    Boraschi D; Meltzer MS
    J Immunol; 1979 Apr; 122(4):1592-97. PubMed ID: 376721
    [No Abstract]   [Full Text] [Related]  

  • 9. Distinct signals for antibody-dependent and nonspecific killing of tumor targets mediated by macrophages.
    Ralph P; Williams N; Nakoinz I; Jackson H; Watson JD
    J Immunol; 1982 Jul; 129(1):427-32. PubMed ID: 7045225
    [No Abstract]   [Full Text] [Related]  

  • 10. Macrophage functions in Biozzi mice.
    Dockrell HM; Taverne J; Lelchuk R; Depledge P; Brown IN; Playfair JH
    Immunology; 1985 Jul; 55(3):501-9. PubMed ID: 3894222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor activity of cell-wall skeleton of Propionibacterium acnes C7 in mice and guinea pigs.
    Azuma I; Yamawaki M; Yoshimoto T; Saiki I; Uemiya M; Tanio Y; Tokuzen R; Yasumoto K; Yamamura Y
    Gan; 1979 Dec; 70(6):737-48. PubMed ID: 395008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of biological significance of in vitro Brugia malayi microfilarial cytotoxicity mediated by Propionibacterium acnes ("Corynebacterium parvum")-and Mycobacterium bovis BCG-activated macrophages.
    Fanning MM; Kazura JW
    Infect Immun; 1986 May; 52(2):534-7. PubMed ID: 3516877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Augmentation of specific macrophage-mediated cytotoxicity: correlations with agents which enhance antitumor resistance.
    Schultz RM; Papamatheakis JD; Stylos WA; Chirigos MA
    Cell Immunol; 1976 Aug; 25(2):309-16. PubMed ID: 782731
    [No Abstract]   [Full Text] [Related]  

  • 14. Expression of a new cell surface antigen on activated murine macrophages.
    Kaplan AM; Mohanakumar T
    J Exp Med; 1977 Nov; 146(5):1461-6. PubMed ID: 925608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [BCG and experimental leukemia].
    Amiel JL; Berardet M
    Ann Inst Pasteur (Paris); 1972 Apr; 122(4):701-14. PubMed ID: 4559236
    [No Abstract]   [Full Text] [Related]  

  • 16. Genetic aspects of macrophage activation for tumor cytotoxicity.
    Boraschi D
    Adv Exp Med Biol; 1982; 141():119-28. PubMed ID: 7046393
    [No Abstract]   [Full Text] [Related]  

  • 17. Imbalanced accumulation of ribosomal RNA in macrophages activated in vivo or in vitro to a cytolytic stage.
    Varesio L
    J Immunol; 1985 Feb; 134(2):1262-7. PubMed ID: 3965571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abilities of activated macrophages to manifest tumoricidal activity and to generate reactive nitrogen intermediates: a comparative study in vitro and ex vivo.
    Keller R; Keist R
    Biochem Biophys Res Commun; 1989 Nov; 164(3):968-73. PubMed ID: 2511844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of recombinant human tumor necrosis factor on the induction of murine macrophage tumoricidal activity.
    Hori K; Ehrke MJ; Mace K; Maccubbin D; Doyle MJ; Otsuka Y; Mihich E
    Cancer Res; 1987 Jun; 47(11):2793-8. PubMed ID: 2882835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Similarities among factors that render macrophages tumoricidal in lymphokine and interferon preparations.
    Schultz RM; Chirigos MA
    Cancer Res; 1978 Apr; 38(4):1003-7. PubMed ID: 346202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.